Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Rheum Dis Clin North Am. 2018 Nov;44(4):525-543. doi: 10.1016/j.rdc.2018.06.001. Epub 2018 Sep 7.

Abstract

Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is the most common cause of rapidly progressive glomerulonephritis. ANCAs play an important role in the pathogenesis and diagnosis of AAV. The classic renal lesion in AAV is a pauci-immune necrotizing and crescentic glomerulonephritis. Treatment is divided into 2 phases: (1) induction of remission to eliminate disease activity and (2) maintenance of remission to prevent disease relapse. AAV patients with end-stage renal disease require modification of immunosuppressive strategies and consideration for kidney transplantation. An improved understanding of disease pathogenesis has led to new treatment strategies being tested in clinical trials.

Keywords: ANCA-associated vasculitis; Granulomatosis with polyangiitis; Microscopic polyangiitis; Rapidly progressive glomerulonephritis.

Publication types

  • Review

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / complications
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / immunology
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Disease Progression
  • Glomerulonephritis* / diagnosis
  • Glomerulonephritis* / etiology
  • Humans
  • Immunosuppression Therapy / methods*
  • Prognosis
  • Secondary Prevention

Substances

  • Antibodies, Antineutrophil Cytoplasmic